skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 32,268  for All Library Resources

Results 1 2 3 4 5 next page
Show only
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Correction to: Genetically downregulated Interleukin-6 signalling is associated with a lower risk of frailty
Material Type:
Article
Add to My Research

Correction to: Genetically downregulated Interleukin-6 signalling is associated with a lower risk of frailty

Age and ageing, 2023-03, Vol.52 (3) [Peer Reviewed Journal]

The Author(s) 2023. Published by Oxford University Press on behalf of the British Geriatrics Society. All rights reserved. For permissions, please email: journals.permissions@oup.com ;ISSN: 0002-0729 ;EISSN: 1468-2834 ;DOI: 10.1093/ageing/afad036 ;PMID: 36860177

Full text available

2
POS0860 COMPARING THE EFFICACY OF THE BDMARD SWITCHER GROUP AND JAK CYCLER GROUP IN PATIENTS WITH RHEUMATOID ARTHRITIS WITH FAILURE TO THE JAK INHIBITORS
Material Type:
Article
Add to My Research

POS0860 COMPARING THE EFFICACY OF THE BDMARD SWITCHER GROUP AND JAK CYCLER GROUP IN PATIENTS WITH RHEUMATOID ARTHRITIS WITH FAILURE TO THE JAK INHIBITORS

Annals of the rheumatic diseases, 2023-06, Vol.82 (Suppl 1), p.734-735 [Peer Reviewed Journal]

2023 Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 0003-4967 ;EISSN: 1468-2060 ;DOI: 10.1136/annrheumdis-2023-eular.5422

Full text available

3
Corrigendum: IL-6 as a keystone cytokine in health and disease
Material Type:
Article
Add to My Research

Corrigendum: IL-6 as a keystone cytokine in health and disease

Nature immunology, 2017-11, Vol.18 (11), p.1271-1271 [Peer Reviewed Journal]

COPYRIGHT 2017 Nature Publishing Group ;COPYRIGHT 2017 Nature Publishing Group ;Copyright Nature Publishing Group Nov 2017 ;ISSN: 1529-2908 ;EISSN: 1529-2916 ;DOI: 10.1038/ni1117-1271b ;PMID: 29044237

Full text available

4
Rapid endotheliitis and vascular damage characterize SARS‐CoV‐2 infection in a human lung‐on‐chip model
Material Type:
Article
Add to My Research

Rapid endotheliitis and vascular damage characterize SARS‐CoV‐2 infection in a human lung‐on‐chip model

EMBO reports, 2021-06, Vol.22 (6), p.e52744-n/a [Peer Reviewed Journal]

2021 The Authors ;This article is protected by copyright. All rights reserved. ;2021 EMBO ;ISSN: 1469-221X ;EISSN: 1469-3178 ;DOI: 10.15252/embr.202152744 ;PMID: 33908688

Full text available

5
Issue Information
Material Type:
Article
Add to My Research

Issue Information

The FEBS journal, 2022-10, Vol.289 (19), p.5715-5717 [Peer Reviewed Journal]

Copyright © 2022 Federation of European Biochemical Societies ;ISSN: 1742-464X ;EISSN: 1742-4658 ;DOI: 10.1111/febs.16003

Full text available

6
Monocyte-derived IL-1 and IL-6 are differentially required for cytokine-release syndrome and neurotoxicity due to CAR T cells
Material Type:
Article
Add to My Research

Monocyte-derived IL-1 and IL-6 are differentially required for cytokine-release syndrome and neurotoxicity due to CAR T cells

Nature medicine, 2018-06, Vol.24 (6), p.739-748 [Peer Reviewed Journal]

COPYRIGHT 2018 Nature Publishing Group ;COPYRIGHT 2018 Nature Publishing Group ;Copyright Nature Publishing Group Jun 2018 ;ISSN: 1078-8956 ;EISSN: 1546-170X ;DOI: 10.1038/s41591-018-0036-4 ;PMID: 29808007

Full text available

7
COVID-19: consider cytokine storm syndromes and immunosuppression
Material Type:
Article
Add to My Research

COVID-19: consider cytokine storm syndromes and immunosuppression

The Lancet, 2020-03, Vol.395 (10229), p.1033-1034 [Peer Reviewed Journal]

2020 Elsevier Ltd ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;2020. Elsevier Ltd ;2020 Elsevier Ltd. All rights reserved. 2020 Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(20)30628-0 ;PMID: 32192578

Digital Resources/Online E-Resources

8
Correction: Synthesis of IL-6 by Hepatocytes Is a Normal Response to Common Hepatic Stimuli
Material Type:
Article
Add to My Research

Correction: Synthesis of IL-6 by Hepatocytes Is a Normal Response to Common Hepatic Stimuli

PloS one, 2019-10, Vol.14 (10), p.e0224498-e0224498 [Peer Reviewed Journal]

2019 Norris et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2019 Norris et al 2019 Norris et al ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0224498 ;PMID: 31644563

Full text available

9
Targeting the IL-6/JAK/STAT3 signalling axis in cancer
Material Type:
Article
Add to My Research

Targeting the IL-6/JAK/STAT3 signalling axis in cancer

Nature reviews. Clinical oncology, 2018-04, Vol.15 (4), p.234-248 [Peer Reviewed Journal]

COPYRIGHT 2018 Nature Publishing Group ;COPYRIGHT 2018 Nature Publishing Group ;Copyright Nature Publishing Group Apr 2018 ;ISSN: 1759-4774 ;EISSN: 1759-4782 ;DOI: 10.1038/nrclinonc.2018.8 ;PMID: 29405201

Full text available

10
Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia
Material Type:
Article
Add to My Research

Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia

Nature medicine, 2018-05, Vol.24 (5), p.563-571 [Peer Reviewed Journal]

COPYRIGHT 2018 Nature Publishing Group ;Copyright Nature Publishing Group May 2018 ;The Author(s) 2018. ;ISSN: 1078-8956 ;EISSN: 1546-170X ;DOI: 10.1038/s41591-018-0010-1 ;PMID: 29713085

Full text available

11
Translating IL-6 biology into effective treatments
Material Type:
Article
Add to My Research

Translating IL-6 biology into effective treatments

Nature reviews. Rheumatology, 2020-06, Vol.16 (6), p.335-345 [Peer Reviewed Journal]

COPYRIGHT 2020 Nature Publishing Group ;Springer Nature Limited 2020. ;Springer Nature Limited 2020 ;ISSN: 1759-4790 ;EISSN: 1759-4804 ;DOI: 10.1038/s41584-020-0419-z ;PMID: 32327746

Full text available

12
CAR T cell-induced cytokine release syndrome is mediated by macrophages and abated by IL-1 blockade
Material Type:
Article
Add to My Research

CAR T cell-induced cytokine release syndrome is mediated by macrophages and abated by IL-1 blockade

Nature medicine, 2018-06, Vol.24 (6), p.731-738 [Peer Reviewed Journal]

COPYRIGHT 2018 Nature Publishing Group ;COPYRIGHT 2018 Nature Publishing Group ;Copyright Nature Publishing Group Jun 2018 ;The Author(s) 2018. ;ISSN: 1078-8956 ;EISSN: 1546-170X ;DOI: 10.1038/s41591-018-0041-7 ;PMID: 29808005

Full text available

13
Overactivation of IL6 cis‑signaling in leukocytes is an inflammatory hallmark of deep vein thrombosis
Material Type:
Article
Add to My Research

Overactivation of IL6 cis‑signaling in leukocytes is an inflammatory hallmark of deep vein thrombosis

Molecular medicine reports, 2022-04, Vol.25 (4), Article 136

COPYRIGHT 2022 Spandidos Publications ;Copyright Spandidos Publications UK Ltd. 2022 ;ISSN: 1791-2997 ;EISSN: 1791-3004 ;DOI: 10.3892/mmr.2022.12652 ;PMID: 35191519

Full text available

14
POS0862 PRESCRIPTION PATTERN OF JAK INHIBITORS OVER 5 YEARS IN ITALY: DATA FROM THE ITALIAN NATIONAL GISEA REGISTRY
Material Type:
Article
Add to My Research

POS0862 PRESCRIPTION PATTERN OF JAK INHIBITORS OVER 5 YEARS IN ITALY: DATA FROM THE ITALIAN NATIONAL GISEA REGISTRY

Annals of the rheumatic diseases, 2023-06, Vol.82 (Suppl 1), p.735-736 [Peer Reviewed Journal]

2023 Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 0003-4967 ;EISSN: 1468-2060 ;DOI: 10.1136/annrheumdis-2023-eular.5537

Full text available

15
Rituximab versus tocilizumab in rheumatoid arthritis: synovial biopsy-based biomarker analysis of the phase 4 R4RA randomized trial
Material Type:
Article
Add to My Research

Rituximab versus tocilizumab in rheumatoid arthritis: synovial biopsy-based biomarker analysis of the phase 4 R4RA randomized trial

Nature medicine, 2022-06, Vol.28 (6), p.1256-1268 [Peer Reviewed Journal]

2022. Crown. ;Crown 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Crown 2022 ;ISSN: 1078-8956 ;EISSN: 1546-170X ;DOI: 10.1038/s41591-022-01789-0 ;PMID: 35589854

Full text available

16
Pharmaco-Immunomodulatory Therapy in COVID-19
Material Type:
Article
Add to My Research

Pharmaco-Immunomodulatory Therapy in COVID-19

Drugs (New York, N.Y.), 2020-09, Vol.80 (13), p.1267-1292 [Peer Reviewed Journal]

Springer Nature Switzerland AG 2020 ;Copyright Springer Nature B.V. Sep 2020 ;ISSN: 0012-6667 ;EISSN: 1179-1950 ;DOI: 10.1007/s40265-020-01367-z ;PMID: 32696108

Full text available

17
POS0639 SWITCHING FROM IL-6R ANTAGONISTS TO OLOKIZUMAB, A DIRECT IL-6 INHIBITOR
Material Type:
Article
Add to My Research

POS0639 SWITCHING FROM IL-6R ANTAGONISTS TO OLOKIZUMAB, A DIRECT IL-6 INHIBITOR

Annals of the rheumatic diseases, 2023-06, Vol.82 (Suppl 1), p.595-596 [Peer Reviewed Journal]

2023 Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 0003-4967 ;EISSN: 1468-2060 ;DOI: 10.1136/annrheumdis-2023-eular.1839

Full text available

18
Therapeutic interleukin-6 blockade reverses transforming growth factor-beta pathway activation in dermal fibroblasts: insights from the faSScinate clinical trial in systemic sclerosis
Material Type:
Article
Add to My Research

Therapeutic interleukin-6 blockade reverses transforming growth factor-beta pathway activation in dermal fibroblasts: insights from the faSScinate clinical trial in systemic sclerosis

Annals of the rheumatic diseases, 2018-09, Vol.77 (9), p.1362-1371 [Peer Reviewed Journal]

Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted. ;2018 Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted. 2018 ;ISSN: 0003-4967 ;EISSN: 1468-2060 ;DOI: 10.1136/annrheumdis-2018-213031 ;PMID: 29853453

Full text available

19
257 IL-6 trans-signaling causes accelerated atherosclerosis in disease-prone animals
Material Type:
Article
Add to My Research

257 IL-6 trans-signaling causes accelerated atherosclerosis in disease-prone animals

Rheumatology (Oxford, England), 2018-04, Vol.57 (suppl_3) [Peer Reviewed Journal]

The Author(s) 2018. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For permissions, please email: journals.permissions@oup.com 2018 ;The Author(s) 2018. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For permissions, please email: journals.permissions@oup.com ;ISSN: 1462-0324 ;EISSN: 1462-0332 ;DOI: 10.1093/rheumatology/key075.481

Full text available

20
FDA Approval Summary: Tocilizumab for Treatment of Chimeric Antigen Receptor T Cell‐Induced Severe or Life‐Threatening Cytokine Release Syndrome
Material Type:
Article
Add to My Research

FDA Approval Summary: Tocilizumab for Treatment of Chimeric Antigen Receptor T Cell‐Induced Severe or Life‐Threatening Cytokine Release Syndrome

The oncologist (Dayton, Ohio), 2018-08, Vol.23 (8), p.943-947 [Peer Reviewed Journal]

Published 2018. This article is a U.S. Government work and is in the public domain in the USA ;Published 2018. This article is a U.S. Government work and is in the public domain in the USA. ;ISSN: 1083-7159 ;EISSN: 1549-490X ;DOI: 10.1634/theoncologist.2018-0028 ;PMID: 29622697

Full text available

Results 1 - 20 of 32,268  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (31,007)

Refine My Results

Creation Date 

From To
  1. Before 1993  (196)
  2. 1993 To 1999  (664)
  3. 2000 To 2006  (894)
  4. 2007 To 2014  (4,240)
  5. After 2014  (26,191)
  6. More options open sub menu

Subject 

  1. Interleukin 6  (30,816)
  2. Science & Technology  (27,965)
  3. Life Sciences & Biomedicine  (22,364)
  4. Inflammation  (20,312)
  5. Cytokines  (16,379)
  6. Humans  (11,823)
  7. Tumor Necrosis Factor-Α  (11,696)
  8. Animals  (9,814)
  9. Proteins  (8,154)
  10. Gene Expression  (7,386)
  11. Male  (7,366)
  12. Tumor Necrosis Factor-Tnf  (6,740)
  13. Female  (6,301)
  14. Mice  (5,873)
  15. Science & Technology - Other Topics  (5,535)
  16. Multidisciplinary Sciences  (5,421)
  17. Immunology  (4,834)
  18. Interleukin 10  (4,817)
  19. Signal Transduction  (4,724)
  20. Il-1β  (4,561)
  21. More options open sub menu

Language 

  1. English  (32,046)
  2. Japanese  (4,043)
  3. German  (126)
  4. Portuguese  (97)
  5. Russian  (76)
  6. Chinese  (38)
  7. Norwegian  (33)
  8. French  (27)
  9. Spanish  (22)
  10. Polish  (8)
  11. Korean  (7)
  12. Italian  (6)
  13. Persian  (6)
  14. Czech  (5)
  15. Slovak  (4)
  16. Croatian  (4)
  17. Indonesian  (3)
  18. Turkish  (3)
  19. Romanian  (3)
  20. Ukrainian  (2)
  21. More options open sub menu

Searching Remote Databases, Please Wait